Skip to main content
Sona Nanotech Inc. logo

Sona Nanotech Inc. — Investor Relations & Filings

Ticker · SONA ISIN · CA83541C1059 CSE Professional, scientific and technical activities
Open in API
Filings indexed 424 across all filing types
Latest filing 2022-04-01 Regulatory Filings
Country CA Canada
Listing CSE SONA

About Sona Nanotech Inc.

https://www.sonanano.com/

Sona Nanotech Inc. is a life sciences company specializing in the development and commercialization of proprietary, uniquely biocompatible gold nanorod (GNR) technology. The primary therapeutic focus is Targeted Hyperthermia Therapy (THT), a photothermal cancer treatment utilizing GNRs to deliver precision heat directly to solid tumors. THT is designed to reduce tumor burden and stimulate immunogenic cell death while minimizing harm to healthy tissue. Sona is advancing THT through clinical trials for solid cancers, including melanoma. Furthermore, the company manufactures and supplies its patented, CTAB-free gold nanoparticles (nanorods and nanospheres) for integration into advanced materials science and medical diagnostic applications, such as lateral flow assays.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Regulatory Filings
2022-04-01 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-04-01 English
Notice of meeting - English.pdf
Regulatory Filings
2022-03-23 English
Annual information form - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'ANNUAL INFORMATION FORM' for the fiscal year ended October 31, 2021, and is from Sona Nanotech Inc. It includes detailed sections such as corporate structure, business description, risk factors, dividends, capital structure, market for securities, directors and officers, legal proceedings, audit committee, and management interests. It also references incorporated documents like audited financial statements and management discussion and analysis for the fiscal years ending October 31, 2019, 2020, and 2021. The document is comprehensive and contains substantive financial and corporate information typical of an Annual Information Form (AIF), which is a regulatory filing used primarily in Canada to provide detailed annual disclosure about a company. This type of document is distinct from an Annual Report (10-K) but serves a similar purpose in providing annual comprehensive information about the company. Given the detailed nature and the title, the document fits best under the category of Regulatory Filings (RNS) because the AIF is a regulatory disclosure document rather than a full annual report or earnings release. The document is lengthy (15,000 characters) and contains detailed information, not just an announcement or certification, so it is not an RPA or RNS fallback for short documents. However, since the AIF is a specific regulatory filing distinct from the 10-K or Annual Report category, and given the definitions provided, the best fit is Regulatory Filings (RNS).
2022-02-28 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CFO, certifying the review and fair presentation of the annual filings for the financial year ended October 31, 2021. It explicitly states it is a certification and does not contain the actual financial statements or detailed financial data. The document is short (3107 characters) and serves as an officer certification rather than the full annual report or financial statements. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or other financial reports.
2022-02-28 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the annual filings for the financial year ended October 31, 2021. The document is a certification letter rather than the actual annual report or financial statements. It references the annual filings but does not contain substantive financial data or the report itself. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS). The document length is 3107 characters, which is relatively short and consistent with a certification letter rather than a full report.
2022-02-28 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.